Skip to main content
OpenTrials

Clinical trial condition

Advanced Non Small Cell Lung Cancer

Explore clinical trials studying Advanced Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

19 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Advanced Non Small Cell Lung Cancer trial results

Recruiting

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

NCT06908993

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Besançon - CHU Besançon, France
  • Bordeaux - Institut Bergonie Bordeaux, France
  • Brest - CHU Brest, France
  • Caen - CRLCC Caen, France
View all 29 locations
View Trial Details
Active, not recruiting

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

NCT04685135

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Local Institution - 012-898 Cerritos, California, United States
  • Local Institution - 012-898 D Glendale, California, United States
  • Local Institution - 012-910-A Huntington Beach, California, United States
  • Local Institution - 012-910-C Irvine, California, United States
View all 380 locations
View Trial Details
Active, not recruiting

Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

NCT04940325

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Institut Bergonié Bordeaux, France
  • Institut de Cancérologie, CHRU Morvan de Brest Brest, France
  • Centre François Baclesse Caen, France
  • Centre Hospitalier Intercommunal de Créteil Créteil, France
View Trial Details
Active, not recruiting

A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer

NCT05318573

Conditions
Advanced Non Small Cell Lung Cancer, Advanced Urothelial Carcinoma
Locations
  • Cancer and Blood Speciality Clinic Long Beach, California, United States
  • Sharp Memorial Hospital (Oncology Clinical Research) San Diego, California, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
View all 23 locations
View Trial Details
Completed

AZD9291 First Time In Patients Ascending Dose Study

NCT01802632

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +13 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

NCT02157883

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +9 more
Locations
  • Research Site San Diego, California, United States
  • Research Site Cleveland, Ohio, United States
  • Research Site Edegem, Belgium
  • Research Site Ghent, Belgium
View all 16 locations
View Trial Details

Related conditions